Disclosure Table

The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:

________________________________________________________________________________________________________

Offeree:  Strongbridge Biopharma plc

Offer period commenced:   24 May 2021

$0.01 ordinary shares; ISIN: IE00BYZ5XL97; NSI: 67,828,952

Offeror:  Xeris Pharmaceuticals, Inc.

$0.001 common stock; ISIN US98422L1070; NSI: 66,497,370

________________________________________________________________________________________________________

Offeree:  UDG Healthcare plc

Offer period commenced:   12 May 2021

€0.05 ordinary shares; ISIN: IE0033024807; NSI: 251,974,223

Offeror:  Nenelite Limited, a company controlled by Clayton, Dubilier & Rice, LLC

Disclosure of interests and dealings in the relevant securities of the above offeror is not required.

_______________________________________________________________________________________________________

Download the Disclosure Table in Other Formats

Download in Excel  xlsicon | Download in CSV csvicon | Download in XML xmlicon